Company / Depreciation & Amortization
Vanda Pharmaceuticals Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$920.0K
FY2025
5-year range
$920.0K / $1.4M
FY2021-FY2025
Trend
-24.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 5 consecutive years, from $1M in FY2020 to $920,000 in FY2025.
Based on SEC 10-K filings.
$920,000 in FY2025 with a 5-year CAGR of -8.4%.
Improved from $1M to $920,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -12.8%
- 5-Year CAGR
- -8.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s depreciation & amortization has declined for 5 consecutive years.
- 5-year CAGR of -8.4%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 24.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $920.0K | -24.4% |
| FY2024 | $1.2M | -10.7% |
| FY2023 | $1.4M | -1.7% |
| FY2022 | $1.4M | -0.1% |
| FY2021 | $1.4M | -2.9% |
| FY2020 | $1.4M | +15.8% |
| FY2019 | $1.2M | +32.0% |
| FY2018 | $935.0K | +60.7% |
| FY2017 | $582.0K | +9.8% |
| FY2016 | $530.0K | +22.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026